Bruce Booth, who writes an informative and insightful blog about early stage life science venture capital, posts regularly about trends within the biotech industry, and recently about expectations for 2012. It seems the primary theme from this year’s Annual J.P. Morgan conference is innovation. Before going further, this requires some analysis. Innovation, a.k.a. Novelty, means […]
